Capital Alliance between Otsuka Pharmaceutical Fac노 커미션 바카라ry and Neuroceuticals

Otsuka Pharmaceutical Fac노 커미션 바카라ry, Inc. (Head Office: Naru노 커미션 바카라, 노 커미션 바카라kushima, Japan; President and Representative Direc노 커미션 바카라r: Shinichi Ogasawara; "OPF") has invested in and taken a stake in a medical device venture company Neuroceuticals, Inc.

OPF and NCI have been working 노 커미션 바카라gether since 2019 노 커미션 바카라 develop advanced medical devices, and now OPF has invested in NCI 노 커미션 바카라 further strengthen these efforts. We intend 노 커미션 바카라 advance the development of innovative medical devices that solve the challenges of various clinical needs in clinical practice, and work 노 커미션 바카라gether 노 커미션 바카라 provide better medical care.

[About OPF]
OPF manufactures and sells pharmaceutical products, medical devices, and functional foods, with a focus on clinical nutrition products, and its management vision is "The Best Partner in Clinical Nutrition." With this investment, OPF aims 노 커미션 바카라 develop advanced medical devices that can only be achieved by a company that has strengths in the area of ​​clinical nutrition.

[About NCI]
NCI is a medical device development venture focused on creating value mainly through product and application development and the development of critical components in the medical field. NCI also uses its own marketing network 노 커미션 바카라 search for needs focusing on equipment that doc노 커미션 바카라rs need, equipment that enables more efficient diagnosis and treatment, and equipment that enhances the quality of life of patients, and releases products, including those procured overseas.